TOPIGEN Pharmaceuticals Inc.
Innovators in Respiratory Therapeutics
TOPIGEN Pharmaceuticals is developing a clinical pipeline of innovative therapeutics for respiratory diseases, including asthma and COPD. The Company’s unique, multi-targeted oligonucleotide product candidates have compelling therapeutic profiles that address major unmet medical needs.
TOPIGEN’s business strategy is to advance products through clinical proof of concept and out-license to partners for commercialization.
